Back to School: How biopharma can reboot drug development. Access exclusive analysis here

PBI-1402: Phase Ib/II data

In a Phase Ib/II trial, 10 of 12 evaluable patients receiving PBI-1402 had

Read the full 139 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE